
Robitussin Honey Cough Syrup Recalled Due to Fungal Threat
THURSDAY, Jan . 25, 2024 (HealthDay News) -- The maker of Robitussin has recalled eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult cough syrups.
The products, which are made by Haleon, may be contaminated with a microbe, and "in immunocompromised individuals, the use of the affected product could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection," the recall notice said.
Fungemia is a fungal infection of the blood.
In people with healthy immune systems, infection is unlikely to lead to severe illness, "however, the occurrence of an infection that may necessitate medical intervention cannot be completely ruled out," the company said.
Haleon says that no illnesses in customers using the product have yet been reported.
The recall only pertains to eight specific lots, which are listed in the full company announcement posted by the FDA.
Customers who know they have purchased one of the recalled products should not use them, and they should reach out to Haleon at 1-800-245-1040 (Monday through Friday 8 a.m. to 6 p.m. Eastern Time) or via email to mystory.us@haleon.com.
SOURCE: Haleon, recall notice, Jan. 24, 2024
What This Means for You:
The maker of Robitussin is recalling eight lots of Robitussin Honey CF products due to microbial contamination that could cause fungal disease
Related Articles
Search Allergy Articles
Planning Safe Summer Camp Fun for Kids With Allergies & Asthma
What Is Chronic Sinusitis, and How Is it Treated?
Dangerous Allergies? An Expert Gives Tips to Protect Yourself
Your Allergy Meds Come With Hazards: Be Aware
Tools You Can Use to Control Winter Asthma, Allergy Symptoms
Wildfires in Western U.S., Canada Create Hazardous Air Conditions
Back-to-School Tips to Helping Your Kids Breathe Easier
Asthma Risk Doubles in People With Diabetes
What You Need to Know About FluMist, the Nasal Flu Vaccine
Universal Flu Vaccine Blocks Infection in Mice
Scientists Developing mRNA-Based Vaccine Against H5N1 Bird Flu
Patient Hospitalized in Louisiana With First U.S. Case of Severe Bird Flu
Obesity Raises Risk of Severe Infection, Especially in People With Diabetes